A highly-anticipated scientific paper has landed! This new work challenges current theories in Huntington’s disease research, ...

The targeting of telomeres offers promise for new cancer therapies, which can be aimed at disrupting the mechanisms that ...

To date clinical studies often show a poor B cell-mediated antibody response after an infection or vaccination in those with ...

Introducing DeepMerkel: a machine-learning model that delivers personalized survival predictions for Merkel cell carcinoma, ...

Genetic changes are a significant cause of infertility, impacting over 15% of the global population. TLE6, a major protein ...

Study explains long-standing question of why Huntington’s disease symptoms typically do not appear until midlife even though ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness.

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and therefore flagged by the Incapsula network. Incapsula displays this page for ...

A new study reveals the potential of two compounds in treating retinitis pigmentosa, a blinding genetic disorder. These compounds, identified through virtual screening, have shown promising results in ...